Down Syndrome and Continuous Positive Pressure Therapy
Morphee
Follow-up of the Therapeutic Coverage by Continuous Positive Pressure of the Obstructive Sleep Apnea Syndrome for Down Syndrome Patients
2 other identifiers
interventional
31
1 country
1
Brief Summary
The purpose of this study is to evaluate the efficacy and tolerability of Continuous Positive Pressure for SAOS in Down Syndrome patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2006
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 31, 2006
CompletedFirst Posted
Study publicly available on registry
November 1, 2006
CompletedStudy Start
First participant enrolled
November 16, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2012
CompletedMarch 26, 2019
October 1, 2012
6 years
October 31, 2006
March 23, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Scores on psychometrical and dementia scales after a 3-month treatment period (and if possible, after 12 months)
0 and 3 months
Secondary Outcomes (1)
Tolerability
0, 3 and 12 months
Study Arms (1)
PPC
EXPERIMENTALNight time device for positive pulmonary pressure
Interventions
Nighttime continuous positive pressure device, to be used every day
Eligibility Criteria
You may qualify if:
- Down Syndrome patients with an Obstructive Sleep Apnea Syndrome
- more than 18 years old
You may not qualify if:
- predictable non-compliance of device
- non-compensated cardiopathy
- non-stable thyroxin treatment
- non-stable diabetes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Institut Jerome Lejeunelead
- Fondation Jérôme Lejeunecollaborator
Study Sites (1)
Institut Jerome Lejeune
Paris, 75015, France
Related Publications (1)
Resta O, Barbaro MP, Giliberti T, Caratozzolo G, Cagnazzo MG, Scarpelli F, Nocerino MC. Sleep related breathing disorders in adults with Down syndrome. Downs Syndr Res Pract. 2003 Aug;8(3):115-9. doi: 10.3104/reports.138.
PMID: 14502839BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Martine Conte, M.D.
Institut Jerome Lejeune
- STUDY DIRECTOR
Franck STURTZ, M.D.
Institut Jerome Lejeune
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 31, 2006
First Posted
November 1, 2006
Study Start
November 16, 2006
Primary Completion
October 31, 2012
Study Completion
December 31, 2012
Last Updated
March 26, 2019
Record last verified: 2012-10